about
Management of antipsychotic-related weight gainEuropean clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatmentThe relation between body fat distribution and cardiovascular risk factors in patients with schizophrenia: a cross-sectional pilot studyWeight gain with olanzapine: Drug, gender or age?Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities.Antipsychotic medication: effects on regulation of glucose and lipids.Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism.The assessment and management of antipsychotic-associated metabolic disturbances from a psychiatric perspective.Update on the role of antipsychotics in the treatment of Tourette syndrome.Metabolic side effects of atypical antipsychotics in children: a literature review.Genomics and the future of pharmacotherapy in psychiatry.Weight gain in antipsychotic-naive patients: a review and meta-analysis.Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review.Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review.The impact of weight gain associated with atypical antipsychotic use in schizophrenia.Weight gain with add-on second-generation antipsychotics in bipolar disorder: a naturalistic study.Characterization of olanzapine-induced weight gain in rats.A retrospective analysis of the short-term effects of olanzapine and quetiapine on weight and body mass index in children and adolescents.Weight gain: gained by waiting?The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.
P2860
Q24610124-A299E86E-ADE3-4C27-89AF-489A6846A864Q28972478-D6CC4406-25A8-42F7-AC9A-63D22543F299Q33873589-F2B645BE-3DA4-4419-8F77-CEC4C90FF30DQ34034650-567C0428-3D89-4E61-BF56-930C102CDAFBQ34230366-764A3B2F-5F0D-4545-8C0F-CB3B48F2925EQ34515378-6CE43321-1433-436A-88B2-0BA33113B890Q35115972-06D4BDC1-D9FB-41E5-AF31-B305974E8300Q35752734-26D00F6A-C23B-46A9-9D48-B9CDEAEB7E88Q35839717-63A3B3C4-8408-41E6-A582-4378BFF7B96EQ36258561-8E98FA0D-80A4-458A-ADFF-35A386355A6EQ36951758-95EE8500-6D37-43F9-B6EF-A543EBD07134Q37572952-F4842400-0312-4081-BEEB-705BCC60CBAEQ37917782-F284CDF8-54CF-4D71-A692-E1C026E57762Q38674637-E2F382B0-BD31-4FAC-B06D-96840DE90FFBQ38777526-DEED75A2-B55D-4B4D-B49B-7E444FD5D10EQ38838191-544B31E8-F028-42CE-8F2A-161D4D89DA2BQ44263522-5E25276D-5CE6-472B-B457-1CA5BF1C1F0DQ45013054-E67454D9-A84F-4A13-85AB-7900600F6195Q47443067-3BC73E96-19FB-4408-9E1A-58D56A199099Q49481418-C6FBA0CA-79F9-438F-AFC7-219F4F467C2D
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Weight gain: side effect of atypical neuroleptics?
@ast
Weight gain: side effect of atypical neuroleptics?
@en
type
label
Weight gain: side effect of atypical neuroleptics?
@ast
Weight gain: side effect of atypical neuroleptics?
@en
prefLabel
Weight gain: side effect of atypical neuroleptics?
@ast
Weight gain: side effect of atypical neuroleptics?
@en
P1476
Weight gain: side effect of atypical neuroleptics?
@en
P2093
Müssigbrodt HE
Wetterling T
P304
P356
10.1097/00004714-199908000-00006
P407
P577
1999-08-01T00:00:00Z